Ticlopidine decreases the in vivo activity of CYP2C19 as measured by omeprazole metabolism

AIMS: To examine the effect of ticlopidine administration on the activities CYP2C19 and CYP3 A in vivo using omeprazole as a model substrate. METHODS: A single dose of 40 mg omeprazole was administered orally with or without ticlopidine (300 mg daily for 6 days) to six Japanese extensive metaboliser...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Tateishi, Tomonori, Kumai, Toshio, Watanabe, Minoru, Nakura, Hironori, Tanaka, Masami, Kobayashi, Shinichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Blackwell Science Inc 1999
Gaiak:
Short Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2014235/
https://ncbi.nlm.nih.gov/pubmed/10233213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.1999.00914.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak